Accordingly, treatment with IL-1 blockers was able to normalize the frequency of IL-17 producing cells after SEB stimulation in NLPR3-mutated CAPS patients, either when evaluated as absolute number [Figure 3C) or percentage of CD4+ T cells (Figure 3D). This evidence concerns the gene IL17A and cryopyrin-associated periodic syndrome.